Trinity Biotech plc
TRIB
Rank in Stocks
#19373
Trinity Biotech plc, an Irish enterprise founded in 1992 and headquartered in... Trinity Biotech plc, an Irish enterprise founded in 1992 and headquartered in Bray, is engaged in the acquisition, development, manufacturing, and global distribution of medical diagnostic solutions. The company's reach extends to the Americas, Africa, Asia, and Europe, catering to both clinical laboratory and point-of-care diagnostic markets. Its extensive range of clinical laboratory offerings encompasses diagnostic tests and specialized instrumentation for identifying numerous infectious diseases. These include Lyme disease, sexually transmitted infections like syphilis and herpes, SARS-CoV-2, and a variety of viral pathogens such as Epstein Barr, measles, mumps, toxoplasmosis, cytomegalovirus, rubella, and varicella. Additionally, Trinity Biotech provides in-vitro diagnostic products centered on haemoglobin A1c for the crucial monitoring, diagnosis, and risk assessment of diabetes. The company's product development incorporates diverse assay formats, including immunofluorescence, enzyme-linked immunosorbent (ELISA), Western blot, and line immunoassays. It also supplies a suite of reagent products, including ACE, bile acids, lactate, oxalate, and glucose-6-phosphate dehydrogenase, vital for diagnosing liver and kidney disorders, as well as haemolytic anaemia. Beyond diagnostics, Trinity Biotech serves the life sciences industry and research facilities by supplying raw materials. The company's customer base comprises public health authorities, non-governmental organizations, and both clinical and reference laboratories. Its products are distributed through a dedicated direct sales force, complemented by a broad network of independent distributors and strategic partnerships.
Share Price
$5.34
Last synced: 2026-11-09
Market Cap
$108.17M
Change (1 day)
-6.29%
Change (1 year)
-80.22%
Country
Stock data: Financial Modeling PrepΒ·Updated Β·Not investment adviceΒ·How we calculate this
Trade Trinity Biotech plc (TRIB)
Category
Healthcare
Operating Margin for Trinity Biotech plc (TRIB)
Operating Margin as of November 2026 TTM: -17.97%
According to Trinity Biotech plc's latest financial reports, its current operating margin (TTM) is -17.97%. At the end of 2025 the company had an operating margin of -26.07%.
Operating Margin history for Trinity Biotech plc from 2000 to 2026
Operating Margin at the end of each year
| Year | Operating Margin | Change |
|---|---|---|
| 2026 (TTM) | -17.97% | -31.07% |
| 2025 | -26.07% | -24.17% |
| 2024 | -34.38% | -27.76% |
| 2023 | -47.59% | 94.88% |
| 2022 | -24.42% | -603.51% |
| 2021 | 4.85% | 5,962.50% |
| 2020 | 0.08% | -91.67% |
| 2019 | 0.96% | -71.76% |
| 2018 | 3.40% | -38.52% |
| 2017 | 5.53% | -26.46% |
| 2016 | 7.52% | -43.96% |
| 2015 | 13.42% | -21.98% |
| 2014 | 17.20% | -12.20% |
| 2013 | 19.59% | -5.82% |
| 2012 | 20.80% | 2.72% |
| 2011 | 20.25% | 29.39% |
| 2010 | 15.65% | 39.73% |
| 2009 | 11.20% | -119.73% |
| 2008 | -56.78% | 177.65% |
| 2007 | -20.45% | -1,346.95% |
| 2006 | 1.64% | -75.60% |
| 2005 | 6.72% | -6.41% |
| 2004 | 7.18% | -51.22% |
| 2003 | 14.72% | 18.52% |
| 2002 | 12.42% | 111.22% |
| 2001 | 5.88% | -73.10% |
| 2000 | 21.86% | 0.00% |
Operating Margin for similar companies or competitors
| Company | Operating Margin | Operating Margin Difference | Country |
|---|---|---|---|
| 17.98% | -101.00% |
US
|
|
| 20.38% | -101.13% |
US
|
|
| 43.02% | -102.39% |
CN
|
|
| 32.03% | -101.78% |
US
|
|
| 22.23% | -101.24% |
US
|
What is a company's Operating Margin?
The operating margin is a key indicator to assess the profitability of a company. Higher operating margins are generaly better as they show that a company is able to sell its products or services for much more than their production costs. The operating margin is calculated by dividing a company's earnings by its revenue.
Questions about Trinity Biotech plc's operating margin
What is Trinity Biotech plc's operating margin?
Trinity Biotech plc's operating margin is -17.97%, as of Nov 2026.
What was Trinity Biotech plc's operating margin in 2025?
In 2025, Trinity Biotech plc's operating margin was -26.07%, compared with -34.38% in 2024.
How has Trinity Biotech plc's operating margin changed since 2020?
From 2020 to 2025, Trinity Biotech plc's operating margin was highest in 2021 (4.85%) and lowest in 2023 (-47.59%).
How does Trinity Biotech plc's operating margin compare with similar companies?
Trinity Biotech plc's operating margin (-17.97%) is lower than that of all 5 similar companies listed above. The highest among them is WuXi AppTec Co., Ltd., with 43.02%.